Stay updated on Talazoparib-Irinotecan Combo in Pediatric Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Talazoparib-Irinotecan Combo in Pediatric Solid Tumors Clinical Trial page.

Latest updates to the Talazoparib-Irinotecan Combo in Pediatric Solid Tumors Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedAdded a Tennessee location under Locations; the page revision updated to v3.3.3 and removed references to 'Tennessee Locations' and 'HHS Vulnerability Disclosure'.SummaryDifference0.2%

- Check21 days agoNo Change Detected
- Check28 days agoNo Change Detected
- Check42 days agoChange DetectedThe page now shows Revision: v3.3.2, replacing the previous Revision: v3.2.0. This appears to be an internal version update with no changes to study details or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check50 days agoChange DetectedThe page no longer displays the general operating status notice regarding funding lapses. This change does not affect the study details or how users interact with the trial information.SummaryDifference0.3%

- Check64 days agoChange DetectedNo significant changes observed; only minor formatting tweaks and a timestamp update. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check93 days agoChange DetectedAdded a prominent operating-status notice and a v3.2.0 version tag, replacing the prior v3.1.0 revision.SummaryDifference2%

- Check100 days agoChange Detected- Updated version from v3.0.2 to v3.1.0. - No other content changes detected.SummaryDifference0.1%

Stay in the know with updates to Talazoparib-Irinotecan Combo in Pediatric Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Talazoparib-Irinotecan Combo in Pediatric Solid Tumors Clinical Trial page.